Harrow Inc Share Price Today: Live Updates & Key Insights
Harrow Inc share price today is $38.65, up -8.19%. The stock opened at $41.57 against the previous close of $41.88, with an intraday high of $41.57 and low of $38.2.
Harrow Inc Share Price Chart
Harrow Inc Share Price Performance
Harrow Inc Institutional Holdings
Harrow Inc Market Status
Harrow Inc Fundamentals
Market Cap 1561.08 M
PB Ratio 55.6153
PE Ratio 0.0
Enterprise Value 1802.52 M
Total Assets 399.48 M
Volume 888661
Harrow Inc Company Financials
About Harrow Inc & investment objective
Company Information Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; BYOOVIZ, a LUCENTIS biosimilar indicated for the treatment of patients with Neovascular (Wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV); VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; OPUVIZ, an EYLEA biosimilar indicated for the treatment of patients with Wet AMD, macular edema following RVO, diabetic macular edema (DME), and diabetic retinopathy (DR); MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Organisation Drug Manufacturers - Specialty & Generic
Employees 373
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Francis W. Mullery
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Harrow Inc FAQs
What is the share price of Harrow Inc today?
The current share price of Harrow Inc is $38.65.
Can I buy Harrow Inc shares in India?
Yes, Indian investors can buy Harrow Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Harrow Inc shares in India?
You can easily invest in Harrow Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Harrow Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Harrow Inc.
Can I buy fractional shares of Harrow Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Harrow Inc?
Harrow Inc has a market cap of $1561.08 M.
In which sector does Harrow Inc belong?
Harrow Inc operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Harrow Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Harrow Inc?
The PE ratio of Harrow Inc is N/A and the PB ratio is 55.62.